Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells.
Sung Hyun KimMyoung-Ok KimKi-Rim Kim
Published in: Journal of cancer prevention (2018)
These results suggest that the anti-growth activity of tyrosine kinase inhibitors may be associated with the regulation of p27/p21 and caspases through Skp2 blockage in HCC cells.